Xin Tong

3.5k total citations
32 papers, 774 citations indexed

About

Xin Tong is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Xin Tong has authored 32 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Xin Tong's work include Influenza Virus Research Studies (4 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xin Tong is often cited by papers focused on Influenza Virus Research Studies (4 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xin Tong collaborates with scholars based in United States, China and Australia. Xin Tong's co-authors include Jill C. Pelling, Olga V. Volpert, Adnan O. Abu‐Yousif, Aubrey R. Morrison, Honglin Li, Kimberly A. Smith, Rukiyah Van Dross, Pu Wang, Boping Ye and Salida Mirzoeva and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Xin Tong

30 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Tong United States 16 406 159 112 88 80 32 774
Elisa Pierpaoli Italy 20 387 1.0× 102 0.6× 56 0.5× 26 0.3× 110 1.4× 42 865
Youness Limami Morocco 18 404 1.0× 72 0.5× 71 0.6× 45 0.5× 40 0.5× 43 1.1k
Chong Kook Kim South Korea 15 590 1.5× 72 0.5× 118 1.1× 49 0.6× 75 0.9× 29 1.1k
Seung-Il Jeong South Korea 17 431 1.1× 79 0.5× 39 0.3× 68 0.8× 65 0.8× 60 968
Tae Kwun Ha South Korea 18 221 0.5× 62 0.4× 63 0.6× 21 0.2× 46 0.6× 57 933
Pooja Sharma India 12 654 1.6× 76 0.5× 91 0.8× 22 0.3× 44 0.6× 32 1.2k
Ren Xiang Tan China 15 407 1.0× 258 1.6× 61 0.5× 20 0.2× 46 0.6× 19 810
Jixia Li China 15 347 0.9× 51 0.3× 32 0.3× 38 0.4× 103 1.3× 43 673
Jae In Jung South Korea 17 548 1.3× 136 0.9× 80 0.7× 15 0.2× 161 2.0× 50 1.0k
Shinji Higa Japan 14 451 1.1× 153 1.0× 94 0.8× 251 2.9× 43 0.5× 30 1.5k

Countries citing papers authored by Xin Tong

Since Specialization
Citations

This map shows the geographic impact of Xin Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Tong more than expected).

Fields of papers citing papers by Xin Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Tong. The network helps show where Xin Tong may publish in the future.

Co-authorship network of co-authors of Xin Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Tong. A scholar is included among the top collaborators of Xin Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Tong. Xin Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jian, Jie Zhan, Zhiyi Zhang, et al.. (2025). Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody. Virulence. 16(1). 2534079–2534079.
2.
Tong, Xin, Hope E. Burks, Ziyou Ren, et al.. (2024). Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAFV600E-Induced Cellular Senescence in Human Melanocytes. Journal of Investigative Dermatology. 145(7). 1740–1752.e4. 1 indexed citations
3.
Wang, Jian, Zhiyi Zhang, Yuanyuan Li, et al.. (2024). Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase. Virology Journal. 21(1). 127–127. 5 indexed citations
4.
Ma, Xiaoyan, Yee Hui Yeo, Zhiwen Fan, et al.. (2024). The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology International. 18(3). 952–963. 3 indexed citations
5.
Du, Haixia, Huifen Zhou, Jiehong Yang, et al.. (2022). Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus. BioMed Research International. 2022(1). 1040129–1040129. 4 indexed citations
6.
Fan, Hua, et al.. (2021). A competitive PCR‐based method to detect a single copy of T‐DNA insertion in transformants. Physiologia Plantarum. 173(3). 1179–1188. 2 indexed citations
7.
Zhao, Xiang‐An, Jian Wang, Jiacheng Liu, et al.. (2021). Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. Journal of Clinical and Translational Hepatology. 10(2). 247–253. 7 indexed citations
8.
Yang, Li, Shengxia Yin, Xin Tong, et al.. (2021). B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 14 indexed citations
9.
He, Feng, Li Shi, Qian Liu, et al.. (2020). Necroptotic TNFα-Syndecan 4-TNFα Vicious Cycle as a Therapeutic Target for Preventing Temporomandibular Joint Osteoarthritis. Journal of Bone and Mineral Research. 37(5). 1044–1055. 25 indexed citations
10.
Tong, Xin, Dandan Xu, Rama K. Mishra, et al.. (2020). Identification of a druggable protein–protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1. Journal of Biological Chemistry. 296. 100098–100098. 24 indexed citations
12.
Li, Wěi, et al.. (2018). Fatal pulmonary infection with respiratory syncytial virus in an immunocompromised adult patient. Medicine. 97(29). e11528–e11528. 3 indexed citations
13.
Mirzoeva, Salida, et al.. (2018). Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor. Neoplasia. 20(9). 930–942. 47 indexed citations
14.
Wang, Pu, et al.. (2016). Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention. Cellular Signalling. 28(5). 460–468. 77 indexed citations
15.
Tong, Xin & Jill C. Pelling. (2013). Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention. Anti-Cancer Agents in Medicinal Chemistry. 13(7). 971–978. 95 indexed citations
16.
Tong, Xin, et al.. (2012). Abstract 1587: AMPK-mTOR axis as key target for chemoprevention of UV-induced skin cancer by the bioflavonoid apigenin. Cancer Research. 72(8_Supplement). 1587–1587. 3 indexed citations
17.
Tong, Xin & Jill C. Pelling. (2008). Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA‐binding protein HuR. Molecular Carcinogenesis. 48(2). 118–129. 25 indexed citations
18.
Tong, Xin, Rukiyah Van Dross, Adnan O. Abu‐Yousif, Aubrey R. Morrison, & Jill C. Pelling. (2006). Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition. Molecular and Cellular Biology. 27(1). 283–296. 102 indexed citations
19.
Tong, Xin & Honglin Li. (2004). eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Letters. 210(1). 63–71. 40 indexed citations
20.
Tong, Xin, John W. Campbell, Gábor Balázsi, et al.. (2004). Genome-scale identification of conditionally essential genes in E. coli by DNA microarrays. Biochemical and Biophysical Research Communications. 322(1). 347–354. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026